Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 284.67M P/E 34.37 EPS this Y 76.10% Ern Qtrly Grth -
Income -60.18M Forward P/E -9.33 EPS next Y -54.00% 50D Avg Chg -11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 6.34 EPS next 5Y - 52W High Chg -83.00%
Recommedations 1.30 Quick Ratio 6.12 Shares Outstanding 63.68M 52W Low Chg 34.00%
Insider Own 39.15% ROA -58.67% Shares Float 14.86M Beta 0.15
Inst Own 49.93% ROE -104.43% Shares Shorted/Prior 721.37K/428.37K Price 6.53
Gross Margin - Profit Margin - Avg. Volume 767,314 Target Price 17.17
Oper. Margin - Earnings Date - Volume 92,988 Change -5.09%
About Zura Bio Limited

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.

Zura Bio Limited News
05/10/24 Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
05/09/24 Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
04/25/24 Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA)
04/18/24 Zura Bio Announces Oversubscribed $112.5 Million Private Placement
04/08/24 Zura Bio Announces Robert Lisicki as CEO and Director
04/02/24 Insider Buyers At Zura Bio Recover Some Losses, But Still Down US$165k
05:00 AM Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
03/04/24 Zura Bio Announces Participation at March Conferences
02/02/24 Zura Bio Announces Participation at February Investor Conferences
01/08/24 Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
01/03/24 Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
12/04/23 Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok
11/14/23 Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors
11/13/23 Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights
09/12/23 Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute
09/07/23 We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely
09/05/23 Oppenheimer Says These 2 Stocks Could Double Your Money — Here’s Why They Could Jump
08/25/23 Netflix upgraded, Olaplex downgraded: Wall Street's top analyst calls
08/14/23 Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights
06/23/23 Zura Bio to Join the Russell 2000® and Russell 3000® Indexes
ZURA Chatroom

User Image Lorenyk Posted - 5 days ago

$AGL-90% Bullish Chart should be a Good Day ❗️ $TGTX-Watch if break over 18.60 should see 21.00 Bullish $ZURA- Feels like it’s trying to find its price? HOLD $PLSE Just insane week for this company Great Job. Bullish for $13.00 $TELO Add to your watch list easy scalper from 5–>7+ every month Trade at your own Risk have a good Thursday!

User Image shelby1 Posted - 1 week ago

$ELTX Picked up a starter a month ago and forgot about it. Added to my "Get Your Ass in This Bitch" list. Now at the top of my list $BDRX $ZURA $AGBA

User Image shelby1 Posted - 1 week ago

$ZURA Above $6.75 and it goes to $10+ quickly $BDRX $AGBA

User Image Alejos11 Posted - 1 week ago

$ZURA

User Image Alejos11 Posted - 1 week ago

$ZURA

User Image Alejos11 Posted - 1 week ago

$ZURA

User Image JonhanDAO Posted - 1 week ago

Stock: $ZURA Current Price: 6.050000190734863 Open: 5.300000190734863 High: 6.190000057220459 Low: 5.262400150299072 Volume: 356969 Activity: Neutral Entry Price: Private Exit Price: Private Expiry Date: Private Data provided by: https://bit.ly/3V4wZ9k

User Image Alejos11 Posted - 1 week ago

$ZURA from my alert at two now over six 👑👑👑

User Image Tron_G Posted - 1 week ago

$ZURA Zacks upgraded to buy.

User Image Tron_G Posted - 1 week ago

$ZURA

User Image shelby1 Posted - 2 weeks ago

$BDRX $ZURA my top 2 bio techs I'm heavy on in both my IRA and day trading accounts.

User Image Ohzipit Posted - 2 weeks ago

$ZURA RJF update from May 9th. Remain Strong Buy reduced price target from $22 to $17. Page 1.

User Image Ohzipit Posted - 2 weeks ago

$ZURA RJF page 2

User Image shelby1 Posted - 2 weeks ago

$ZURA PAMP IT!

User Image ButterCapital Posted - 2 weeks ago

$ZURA in

User Image IN0V8 Posted - 2 weeks ago

$ZURA Opportunity Oppenheimer raises target price to $21 from $16 Guggenheim cuts target price to $15 from $20 Raymond James cuts target price to $17 from $22

User Image DonCorleone77 Posted - 2 weeks ago

$ZURA Momma can never have too many new shoes!!! Zura Bio price target raised to $21 from $16 at Oppenheimer Oppenheimer raised the firm's price target on Zura Bio to $21 from $16 and keeps an Outperform rating on the shares. Zura reported Q1 financial results and provided an update on their development plans for lead candidate tibulizumab across key indications, the analyst tells investors in a research note. Ending cash of $89.8M should support the company through 2027 based on current plans, the firm says.

User Image DonCorleone77 Posted - 2 weeks ago

$ZURA Zura Bio reports Q1 EPS (2c), consensus (23c) Cash and cash equivalents were $89.8M as of March 31, 2024 vs. $99.8M as of December 31, 2023. Zura Bio anticipates that with the recent private placement factored in, its cash and cash equivalents are sufficient to fund planned operations through 2027. "Our recent financial and business highlights demonstrate how we continue to strengthen the company for future success. Our leadership additions and oversubscribed $112.5 million private placement lay the groundwork for operational success and provide cash runway through 2027. The private placement by leading life sciences investors emphasizes the confidence in our pipeline of novel, dual-pathway antibodies for autoimmune and inflammatory diseases," stated Robert Lisicki, CEO. "We remain focused on the design and on-time execution of our tibulizumab development program with a goal to introduce best in-class therapies to people living with SSc and HS. These are two underserved therapeutic areas where patients may realize the benefit of tibulizumab' s dual-pathway approach, targeting IL-17 and BAFF."

User Image kkbb Posted - 2 weeks ago

$ZURA

User Image Stock_Titan Posted - 2 weeks ago

$ZURA Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights https://www.stocktitan.net/news/ZURA/zura-bio-reports-first-quarter-2024-financial-results-and-recent-azpywolxc0dj.html

User Image shelby1 Posted - 2 weeks ago

$ZURA moon time soon. PDUFAs upcoming.

User Image RollingDollar Posted - 3 weeks ago

$ZURA .

User Image newera21 Posted - 3 weeks ago

$AGBA $AMD $ZURA $GWAV

User Image newera21 Posted - 3 weeks ago

$ZURA beautiful green 💵

User Image stockregion Posted - 3 weeks ago

Zura Bio Garners Enthusiastic Ratings from Analysts with a Bright Outlook. Zura Bio (NASDAQ:ZURA), Piper Sandler, a prestigious investment firm, has initiated coverage on the biotechnology company, assigning it an "overweight" rating and setting an ambitious price target of $26. This optimistic forecast suggests a potential upside of 462.77% from the stock's previous close. The announcement by Piper Sandler underscores a growing confidence in Zura Bio's prospects, aligning with similar sentiments expressed by other market analysts. $ZURA https://stockregion.app/p/biotechnology-company-receives-overweight

User Image Ortho91 Posted - 3 weeks ago

$ZURA accumulation phase now. Add, add, add…..rewards will come eventually sooner than later.

User Image BuyRipzSellDipz Posted - 3 weeks ago

$HOLO $ATOS $OKLO $ZURA - $$$$$$$$$

User Image BuyRipzSellDipz Posted - 3 weeks ago

$JAGX $ARDX $ZURA $IBRX

User Image satsandstocks Posted - 3 weeks ago

$ZURA looking for a day trade. Piper Sandler initiated coverage with overweight and 26$ target (their allies might be one of them who got shares in private placement at 3.10$)

User Image BenKaitz Posted - 3 weeks ago

$ZURA

Analyst Ratings
Oppenheimer Outperform May 10, 24
Piper Sandler Overweight May 3, 24
Oppenheimer Outperform Apr 1, 24
Ladenburg Thalmann Buy Oct 10, 23
Oppenheimer Outperform Aug 25, 23
Raymond James Strong Buy Aug 15, 23
Guggenheim Buy Jun 22, 23
Chardan Capital Buy Jun 14, 23
Raymond James Strong Buy May 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Thiara Parvinder Director Director Dec 12 Sell 4.00 2,000,000 8,000,000 4,801,633 12/14/23
Munshi Amit Director Director Jun 05 Buy 4.25 117,647 500,000 617,640 06/05/23